A nurse is caring for a client who has diabetes mellitus and has been following a treatment plan for 3 months. Which of the following laboratory results should the nurse monitor to determine long-term glycemic control?

Monitoring glycemic control is essential for managing diabetes mellitus and preventing long-term complications such as neuropathy, retinopathy, and nephropathy. While daily blood glucose monitoring provides a "snapshot" of a client's sugar levels at a specific moment in time, it does not reflect how well the blood sugar has been managed over weeks or months. For a client who has been on a treatment plan for 3 months, providers look for a metric that represents the average blood glucose concentration over the entire lifespan of a red blood cell. A. Glycosylated hemoglobin (HbA1c) reflects the average blood glucose level over the past 2 to 3 months by measuring the percentage of hemoglobin bound to glucose. It is the best indicator of long-term glycemic control and is used to evaluate how well a treatment plan is working over time. This makes it the most appropriate test in this scenario. B. Oral glucose tolerance test results are used primarily to diagnose diabetes or impaired glucose tolerance rather than to monitor long-term control. It assesses how the body responds to a glucose load at a specific point in time, not overall long-term management. Therefore, it is not used for ongoing monitoring. C. Fasting blood glucose level measures current blood sugar after a period of fasting and reflects short-term glycemic status. It can vary daily based on diet, stress, or illness, making it less reliable for long-term control assessment compared to HbA1c. D. Postprandial blood glucose level measures blood sugar after meals and reflects short-term glucose control in response to food intake. While useful for daily management adjustments, it does not provide an overall picture of long-term glycemic control.